Trending Medical and health breaking news Positive Phase 3 Topline Results for Early Parkinson’s Drug

Trending Medical and health breaking news Positive Phase 3 Topline Results for Early Parkinson’s Drug

Topline results from a phase 3 trial of P2B001, a fixed-dose combination of extended release (ER) formulations of pramipexole and rasagiline, showed it was superior to its individual components as a first-line treatment for early Parkinson’s disease. Study participants also reported less daytime sleepiness with P2B001, according to a statement from the drug’s manufacturer. The…